Jonathan Van-Tam on COVID’s Next Phase - Top-Institutions - MDSpire

Jonathan Van-Tam on COVID’s Next Phase

Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19

  • By

  • James Strachan

  • Julian Upton

  • April 14, 2026

  • 7 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Vaccine Research

  • #2

    University of Oxford
    University of Oxford

    Oxford, England

    Key Differentiators

    • Vaccine Development
    • Infectious Diseases
    • Public Health

  • #3

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Epidemiology
    • Public Health
    • Infectious Diseases

  • #4

    Imperial College London
    Imperial College London

    London, England

    Key Differentiators

    • Epidemiology
    • Infectious Disease Modeling
    • Vaccine Research

  • #5

    National Institute of Allergy and Infectious Diseases (NIAID)
    National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Vaccine Development
    • Immunology

Original Source(s)

Jonathan Van-Tam on COVID’s Next Phase

  • by James Strachan, Julian Upton

  • April 14, 2026

Related Content

Long COVID as a network disorder: a mechanism-anchored framework for biological stratification and therapeutic targeting

Ebola at the World Cup? Here’s what we should actually worry about

Explainable machine learning-based mortality risk stratification for older adults with COVID-19: pinpointing core immunological biomarkers and revealing dose-threshold effects